MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-441

  1. 7,779 Posts.
    lightbulb Created with Sketch. 1337
    Why are you convinced the tech is good? Why is this the fault of trial design, or the FDA or big pharma, as others keep mentioning?

    Is that why MSC therapies traditionally fail phase three trials? MSB is not the first company to try this.

    I'm not saying it doesn't work. I'm just wondering why, at this stage, people are so convinced it does.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.